DNA encoding a novel human proteolipid
AssigneeIncyte Pharmaceuticals, Inc.
InventorsJanice Au-Young, Olga Bandman, Surya K. Goli, Jennifer L. Hillman
Life of this patent
Estimating the term…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsJanice Au-Young, Olga Bandman, Surya K. Goli, Jennifer L. Hillman
Estimating the term…
The present invention provides polynucleotides which identify and encode a novel human proteolipid (PLHu). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding PLHu. The invention also provides for the use of substantially purified PLHu and its agonists in the commercial production of recombinant proteins for the treatment of diseases associated with the expression of PLHu. Additionally, the invention provides for the use of antisense molecules to PLHu in the treatment of diseases associated with the expression of PLHu. The invention also describes diagnostic assays which utilize diagnostic compositions comprising the polynucleotides which hybridize with naturally occurring sequences encoding PLHu and antibodies which specifically bind to the protein.
A substantially purified polypeptide comprising the amino acid sequence of SEQ ID NO:1.
An isolated and purified polynucleotide sequence fully complementary to the sequence of SEQ ID NO:2 or degenerate variants thereof.
Dependencies are inferred from the claim text.